1 |
Lurain JR (2011). Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol, 204, 11-8.
DOI
ScienceOn
|
2 |
Wang J, Short D, Sebire NJ, et al (2008). Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE). Ann Oncol, 19, 1578-83.
DOI
|
3 |
Hertz R, Li Mc, Spencer Db (1956). Effect of methotrexate therapy upon choriocarcinoma and chorioadenoma. Proc Soc Exp Biol Med, 93, 361-6.
DOI
|
4 |
Limpongsanurak S, Sitthisomwong T (1999). Metastatic Gestational Trophoblastic Neoplasia at King Chulalongkorn Memorial Hospital. Trophoblast Res, 13, 205-11.
|
5 |
Lurain JR, Elfstrand EP (1995). Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumors. Am J Obstet Gynecol, 172, 574-9.
DOI
ScienceOn
|
6 |
Lurain JR, Singh DK, Schink JC (2010). Management of metastatic high-risk gestational trophoblastic neoplasia: FIGO stages II-IV: risk factor score 7. J Reprod Med, 55, 199-207.
|
7 |
Lurain JR, Schink JC (2012). Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia. J Reprod Med, 57, 219-24.
|
8 |
Osborne R, Dodge J (2012). Gestational trophoblastic neoplasia. Obstet Gynecol Clin North Am, 39, 195-212.
DOI
ScienceOn
|
9 |
Patel SM, Desai A (2010). Management of drug resistant gestational trophoblastic neoplasia. J Reprod Med, 55, 296-300.
|
10 |
Roberts JP, Lurain JR (1996). Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol, 174, 1917-23
DOI
ScienceOn
|
11 |
Rodriguez N, Goldstein DP, Berkowitz RS (2010). Treating gestational trophoblastic disease. Expert Opin Pharmacother, 11, 3027-39.
DOI
ScienceOn
|
12 |
Alazzam M, Tidy J, Osborne R, et al (2012). Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia. Cochrane Database Syst Rev, 12, 8891.
|
13 |
Bianconi M, Jankilevich G, Otero S, Nassif J, Storino C (2007). Successful salvage of a relapsed high risk gestational trophoblastic neoplasia patient using capecitabine. Gynecol Oncol, 106, 268-71.
DOI
ScienceOn
|
14 |
Cyriac S, Rajendranath R, Sridevi V, Sagar TG (2011). Etoposide, cisplatin-etoposide, methotrexate, actinomycin-D as primary treatment for management of very-high-risk gestational trophoblastic neoplasia. Int J Gynaecol Obstet, 115, 37-9.
DOI
ScienceOn
|
15 |
Deng L, Zhang J, Wu T, Lawrie TA (2013). Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour. Cochrane Database Syst Rev, 1, 5196.
|
16 |
Feng F, Xiang Y, Wan X, Geng S, Wang T (2011). Salvage combination chemotherapy with floxuridine, dactinomycin, etoposide, and vincristine (FAEV) for patients with relapsed/chemoresistant gestational trophoblastic neoplasia. Ann Oncol, 22, 1588-94.
DOI
ScienceOn
|